Welcome to our dedicated page for Ndt Pharmaceuticals news (Ticker: NDTP), a resource for investors and traders seeking the latest updates and insights on Ndt Pharmaceuticals stock.
NDT Pharmaceuticals, Inc. (NDTP) is a publicly traded health and wellness company whose news flow is closely tied to its wholly owned biosafety subsidiary, Good Salt Life, Inc. Company announcements highlight developments in consumer health products, institutional disinfection technologies, and regulatory milestones that shape its position in the biotechnology and broader healthcare ecosystem.
News about NDT Pharmaceuticals often focuses on Good Salt Life’s expanding biosafety platform, including deployments of the ByoCart and ByoCart Sprayer systems in hospitals and correctional facilities, and the use of Clean Republic hypochlorous acid disinfectants in healthcare, cruise, and animal health environments. Updates also cover contracts and relationships with institutional customers such as Baptist Hospital, the Tennessee Department of Correction, and Norwegian Cruise Line, as well as responses to biosecurity challenges in equine settings.
Investors and observers can also find coverage of product and brand developments, such as the launch and expansion of pet-focused odor-control brands Dog Gone Odor and PurrGuard, the broader Good Salt Life catalog for home and personal care, and progress in EPA registrations and regulatory reviews for Clean Republic Multipurpose Disinfectant. Additional news items describe Good Salt Life’s integration of AI-robotics for unmanned hospital disinfection and the continued evolution of its induction-charged spray and air-scrubbing technologies.
This page aggregates company-issued press releases and related coverage so readers can follow NDT Pharmaceuticals’ strategic moves in biosafety, consumer wellness, and institutional hygiene. For those tracking NDTP, the news feed offers insight into product launches, regulatory developments, major contracts, and technology advancements across the Good Salt Life ecosystem.
Good Salt Life (OTC:NDTP) submitted a "me-too" registration to the U.S. EPA for its hypochlorous acid (HOCl) disinfectant seeking an efficacy claim for Clostridioides difficile (C. diff). If approved, the label expansion would allow marketing to hospitals and healthcare facilities concerned with C. diff infection control. The company cited the U.S. healthcare market exceeding $4 trillion and described partnerships on induction charged spray and air scrubbing technologies to enhance surface and air disinfection. Recent EPA registrations include Dog Gone Odor and PurrGuard. The company is awaiting the EPA decision.
NDT Pharmaceuticals (OTCID:NDTP) announced its subsidiary Good Salt™ Life's strategic expansion into the $148 billion global biosafety market with an innovative antimicrobial platform. The company's technology transforms salt and water into hypochlorous acid (HOCl) solutions through proprietary electrolysis, targeting home care, pet wellness, skincare, and professional biosafety sectors.
Good Salt Life has secured partnerships with major industry leaders including Virgin, Royal Caribbean, Carnival Corp, Cleveland Clinic, New York Yankees, and major retailers like Amazon, Walmart, and Chewy. The company's EPA-registered solutions are being implemented across various sectors including animal health, cruise industry, healthcare, government facilities, and sports venues.
The company is also investing in next-generation technologies including robotics, AI automation, and indoor air quality sensors to build a comprehensive safety solutions ecosystem.
NDT Pharmaceuticals (OTC:NDTP) has completed the acquisition of Good Salt Life, LLC, an Athens, Georgia-based biosafety and infection control innovator, on September 5, 2025. Good Salt Life specializes in infection control ecosystems with proprietary hardware and EPA-approved chemistries, operating across 11 countries and 8 industries.
The acquired company serves major clients including Merck Animal Health, United Airlines, Carnival Cruise Line, Marriott, and the NFL. Good Salt Life's portfolio encompasses consumer pet care, home care, cosmetics, antimicrobial chemistry, and chemical delivery technology. The integration aims to create cleaner, safer, and healthier solutions while focusing on sustainability and innovation.